awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42701148-940BA807-FF1D-4009-8269-A16444A54077
Q42701148-940BA807-FF1D-4009-8269-A16444A54077
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42701148-940BA807-FF1D-4009-8269-A16444A54077
Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy.
P2860
Q42701148-940BA807-FF1D-4009-8269-A16444A54077
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42701148-940BA807-FF1D-4009-8269-A16444A54077
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
23516d4ea8192d6142ec7628995b9973cb0167f6
P2860
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer